SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sudarshan Pharma Industries informs about press release

26 Apr 2025 Evaluate
Sudarshan Pharma Industries has informed that it enclosed the newspaper advertisement for the Audited Standalone and Consolidated Financial Results for the half year and financial year ended 31st March 2025 published in Mumbai Lakhsdeep (Marathi) and Financial Express (English).

The above information is a part of company’s filings submitted to BSE.

Sudarshan Pharma Ind Share Price

31.50 0.38 (1.22%)
13-Apr-2026 11:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1653.60
Dr. Reddys Lab 1224.35
Cipla 1215.75
Zydus Lifesciences 929.30
Lupin 2329.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×